Impact of proton pump inhibitors on benign anastomotic stricture formations after esophagectomy and gastric tube reconstruction: results from a randomized clinical trial. Ann Surg 2009; 250: 667-673.
Published: 1st January 2009
Authors: Johansson J, Oberg S, Wenner J, Zilling T, Johnsson F, von Holstein CS et al. et al.
Eighty patients were randomly allocated a proton pump inhibitor or placebo after their surgery for one year. The active drug reduced the rate of benign anastomotic stricture from 45 to 13 per cent (P=0.001); however, the size of staple cartridge used for the anastomosis was also a significant factor.Pubmed Link
You may also be interested in
A randomized double blinded study to determine the effectiveness of utilizing intraperitoneal bupivacaine: does it reduce postoperative opioid use following laparoscopic appendectomy? Am J Surg 2019; 217: 479-482.
Authors: Sevensma K, Schleichert T, Shwickerath C, Shoemaker A, Miller C
Efficacy of transversus abdominis plane (TAP) block in pain management after laparoscopic sleeve gastrectomy (LSG): A double-blind randomized controlled trial. Am J Surg 2019; 217: 126-132.
Authors: Saber AA, Lee YC, Arjun C, Namik O, Armand A, Al-Ayoubi S et al.
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet 2019; 393: 1948-1957.
Authors: Al-Batran S-E, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S et al.
Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer. A randomized controlled trial. Ann Surg 2019; 269: 621-630.
Authors: van der Sluis PC, van der Horst S, May AM, Schippers C, Brosens L, Joore HC et al.
Efficacy of preoperative oral antibiotic prophylaxis for the prevention of surgical site infections in patients with Crohn’s Disease. A Randomized Controlled Trial. Ann Surg 2019; 269: 420-426.
Authors: Uchino M, Ikeuchi H, Bando T, Chohno T, Sasaki H, Horio Y et al.
Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. Lancet 2019; 393: 1299-1309.
Authors: Maud R, Espalieu P, Pelascini E, Caiazzo R, Sterkers A, Khamphommala L et al.
Effect of perioperative oral nutritional supplementation in malnourished patients who undergo gastrectomy: a prospective randomized trial. Surgery 2018; 164: 1263-1270.
Authors: Kong S-H, Lee H-J, Na J-R, Kim WG, Han D-S, Park S-H et al.
Effect of exercise and nutrition prehabilitation on functional capacity in esophagogastric cancer surgery. A randomized clinical trial. JAMA Surg 2018; 153: 1081-1089.
Authors: Minnella EM, Awasthi R, Loiselle S-E, Agnihotram RV, Ferri LE, Carli F et al.
Authors: Mariette C, Markar SR, Dabakuyo-Yonli TS, Meunier B, Pezet D, Collet D et al.
Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical trial. J Clin Oncol 2018; 36: 2796-2803.
Authors: Yang H, Liu Y, Chen Y, Zhu C, Fang W, Yu Z et al.
Effectiveness of fibrin sealant application on the development of staple line complications after sleeve gastrectomy: a prospective randomized trial. Ann Surg 2018; 268: 762-768.
Authors: Rebibo L, Dhahri A, Chati R, Cosse C, Huet E, Regimbeau J-M et al.
The RESTORE randomized controlled trial: impact of a multidisciplinary rehabilitative program on cardiorespiratory fitness in esophagogastric cancer survivorship. Ann Surg 2008; 268: 747-755.
Authors: O’Neill L, Guinan E, Doyle S, Bennett AE, Murphy C, Elliott JA et al.